Copper and the prion protein: Methods, structures, function, and disease

Annual Review of Physical Chemistry

Volumn 58, Issue , 2007, Pages 299-320

  Millhauser, Glenn L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Electron paramagnetic resonance; Neuroprotection; Octarepeat domain; Transmissible spongiform encephalopathies

Indexed keywords

CELL DEATH; COPPER; DISEASES; PARAMAGNETIC RESONANCE;

ENCEPHALOPATHY; NEUROPROTECTION; OCTAREPEAT DOMAIN; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSE);

PROTEINS;

COPPER;

ANIMAL; CHEMISTRY; ELECTRON SPIN RESONANCE; GENERAL ASPECTS OF DISEASE; HUMAN; METABOLISM; METHODOLOGY; PRION; PROTEIN CONFORMATION; REVIEW;

ANIMALS; COPPER; DISEASE; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; PRIONS; PROTEIN CONFORMATION;

EID: 34249941302     PISSN: 0066426X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physchem.58.032806.104657     Document Type: Article

References (95)

1. Prusiner SB. 1991. Molecular biology of prion diseases. Science 252:1515-22
2. Prusiner SB. 1997. Prion diseases and the BSE crisis. Science 278:245-51
3. Prusiner SB. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-83
4. Weissmann C. 2004. The state of the prion. Nat. Rev. Microbiol. 2:861-71
5. Prusiner SB. 2003. Prion Biology and Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press. 800 pp
6. Lansbury PTJ. 1997. Structural neurology: Are seeds at the root of neuronal degeneration? Neuron 19:1151-54
7. Pauli G. 2005. Tissue safety in view of CJD and variant CJD. Cell Tissue Bank 6:191-200
8. Miller MW, Williams ES, McCarty CW, Spraker TR, Kreeger TJ, et al. 2000. Epizootiology of chronic wasting disease in free-ranging cervids in Colorado and Wyoming. J. Wildl. Dis. 36:676-90
9. Horby P. 2002. Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins. J. Paediatr. Child. Health 38:539-42
10. Ironside JW. 2003. The spectrum of safety: variant Creutzfeldt-Jakob disease in the United Kingdom. Semin. Hematol. 40:16-22
11. Ironside JW, Head MW. 2004. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products. Haemophilia 10(Suppl. 4):64-69
12. Flechsig E, Weissmann C. 2004. The role of PrP in health and disease. Curr: Mol. Med. 4:337-53
13. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, et al. 2000. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97:145-50
14. James TL, Liu H, Nikolai BU, Farr-Jones S, Zhang H, et al. 1997. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94:10086-91
15. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K. 1996. NMR structure of the mouse prion protein domain PrP(121-321). Nature 382:180-82
16. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. 1997. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:282-88
17. Govaerts C, Wille H, Prusiner SB, Cohen FE. 2004. Evidence for assembly of prions with left-handed β-helices into trimers. Proc. Natl. Acad. Sci. USA 101:8342-47
18. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, et al. 2002. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99:3563-68
19. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, et al. 1997. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N-terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94:13452-56
20. Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, et al. 1999. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289:1163-78
21. Prusiner SB. 2001. Shattuck lecture: neurodegenerative diseases and prions. N. Engl. J. Med. 344:1516-26
22. Prusiner SB, Groth D, SerbanA, Stahl N, Gabizon R. 1993. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl. Acad. Sci. USA 90:2793-97
23. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-76
24. Brown DR, Qin K, Herms JW, Madlung A, Manson J, et al. 1997. The cellular prion protein binds copper in vivo. Nature 390:684-87
25. Hornshaw MP, McDermott JR, Candy JM. 1995. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207:621-29
26. Hornshaw MP, McDermott JR, Candy JM, Lakey JH. 1995. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem. Biophys. Res. Commun. 214:993-99
27. Stöckel J, Safar J, Wallace AC, Cohen FE, Prusiner SB. 1998. Prion protein selectively binds copper(II) ions. Biochemistry 37:7185-93
28. Viles JH, Cohen FE, Prusiner SB, Goodin DB, Wright PE, Dyson HJ. 1999. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. USA 96:2042-47
29. Whittal RM, Ball HL, Cohen FE, Burlingame AL, Prusiner SB, Baldwin MA. 2000. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 9:332-43
30. Pauly PC, Harris DA. 1998. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:33107-19
31. Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, et al. 2003. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278:9064-72
32. Millhauser GL. 2004. Copper binding in the prion protein. Acc. Chem. Res. 37:79-85
33. Herms J, Tings T, Gall S, Madlung A, Giese A, et al. 1999. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19:8866-75
34. Hartter DE, Barnea A. 1988. Evidence for release of copper in the brain: depolarization-induced release of newly taken-up 67copper. Synapse 2:412-15
35. Hopt A, Korte S, Fink H, Panne U, Niessner R, et al. 2003. Methods for studying synaptosomal copper release. J. Neurosci. Methods 128:159-72
36. Kardos J, Kovacs I, Hajos F, Kalman M, Simonyi M. 1989. Nerve endings from rat brain tissue release copper upon depolarization: a possible role in regulating neuronal excitability. Neurosci. Lett. 103:139-44
37. Vassallo N, Herms J. 2003. Cellular prion protein function in copper homeostasis and redox signaling at the synapse. J. Neurochem. 86:538-44
38. Brown DR, Schmidt B, Kretzschmar HA. 1998. Effects of copper on survival of prion protein knockout neurons and glia. J. Neurochem. 70:1686-93
39. Klamt F, Dal-Pizzol F, Conte DA, Frota JML, Walz R, et al. 2001. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic. Biol. Med. 30:1137-44
40. Daniels M, Brown DR. 2002. Purification and preparation of prion protein: synaptic Superoxide dismutase. Methods Enzymol. 349:258-67
41. Hutter G, Heppner FL, Aguzzi A. 2003. No Superoxide dismutase activity of cellular prion protein in vivo. Biol. Chem. 384:1279-85
42. Jones S, Batchelor M, Bhelt D, Clarke AR, Collinge J, Jackson GS. 2005. Recombinant prion protein does not possess SOD-1 activity. Biochem. J. 392:309-12
43. Burns CS, Aronoff-Spencer E, Dunham CM, Lario P, Avdievich NI, et al. 2002. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 41:3991-4001
44. Waggoner DJ, Drisaldi B, Bartnikas TB, Casareno RLB, Prohaska JR, et al. 2000. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275:7455-58
45. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, et al. 2000. Signal transduction through prion protein. Science 289:1925-28
46. Roucou X, Gains M, LeBlanc AC. 2004. Neuroprotective functions of prion protein. J. Neurosci. Res. 75:153-61
47. Miura T, Sasaki S, Toyama A, Takeuchi H. 2005. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 44:8712-20
48. Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G. 2005. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J. Neurochem. 95:1373-86
49. Sc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc. Natl. Acad. Sci. USA 101:10254-59
50. Haire LF, Whyte SM, Vasisht N, Gill AC, Verma C, et al. 2004. The crystal structure of the globular domain of sheep prion protein. J. Mol Biol. 336:1175-83
51. Peisach J, Blumberg WE. 1974. Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins. Arch. Biochem. Biophys. 165:691-708
52. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 39:13760-71
53. 2+ binding sites in the C-terminal domain of the murine prion protein: a pulse EPR and ENDOR study. J. Phys. Chem. 105:1631-39
54. Lippard SJ, Berg JM. 1994. Principles of Bioinorganic Chemistry. Mill Valley, CA: Univ. Sci. Books. 411 pp.
55. 2+ ion EPR spectra. J. Phys. Chem. 73:3123-31
56. Yuan H, Antholine WE, Kroneck PMH. 1998. Complexation of type 2 copper by cytochrome c oxidase: probing of metal-specific binding sites by electron paramagnetic resonance. J. Inorg. Biochem. 71:99-107
57. 14N ESEEM patterns of randomly oriented solids. J. Chem. Phys. 87:5606-16
58. 15N. J. Chem. Phys. 69:4921-30
59. Mims WB, Peisach J. 1981. Electron spin echo spectroscopy and the study of metalloproteins. In Biological Magnetic Resonance, ed. LJ Berliner, J Reuben. New York: Plenum
60. McCracken J, Pember S, Benkovic SJ, Villafranca JJ, Miller RJ, Peisach J. 1988. Electron-spin echo studies of the copper-binding site in phenylalanine-hydroxylase from chromobacterium-violaceum. J.Am. Chem. Soc. 110:1069-74
61. Miura T, Hori-i A, Mototani H, Takeuchi H. 1999. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. Biochemistry 38:11560-69
62. Pushie MJ, Rauk A. 2003. Computational studies of Cu(II)[peptide] binding motifs: Cu[HGGG] and Cu[HG] as models for Cu(II) binding to the prion protein octarepeat region. J. Biol. Inorg. Chem. 8:53-65
63. Zahn R. 2003. The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site.J. Mol. Biol. 334:477-88
64. Burns CS, Aronoff-Spencer E, Legname G, Prusiner SB, Antholine WE, et al. 2003. Copper coordination in the full-length, recombinant prion protein. Biochemistry 42:6794-803
65. 2+ ions at physiological concentrations. J. Mol. Biol. 346:1393-407
66. Chattopadhyay M, Walter ED, Newell DJ, Jackson PJ, Aronoff-Spencer E, et al. 2005. The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4 J. Am. Chem. Soc. 127:12647-56
67. Valensin D, Luczkowski M, Mancini FM, Legowska A, Gaggelli E, et al. 2004. The dimeric and tetrameric octarepeat fragments of prion protein behave differently to its monomeric unit. Dalton Trans. 2004:284-93
68. Morante S, Gonzalez-Iglesias R, Potrich C, Meneghini C, Meyer-Klaucke W, et al. 2004. Inter- and intraoctarepeat Cu(II) site geometries in the prion protein: implications in Cu(II) binding cooperativity and Cu(II)-mediated assemblies. J. Biol. Cbem. 279:11753-59
69. Jackson GS, Murray I, Hosszu LLP, Gibbs N, Waltho JP, et al. 2001. Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. USA 98:8531-35
70. Wells MA, Jackson GS, Jones S, Hosszu LL, Craven CJ, et al. 2006. A reassessment of copper (II) binding in the full-length prion protein. Biochem. J. In press
71. Kramer ML, Kratzin HD, Schmidt B, Romer A, Windl O, et al. 2001. Prion protein binds copper within the physiological concentration range. J. Biol. Chem. 276:16711-19
72. Garnett AP, Viles JH. 2003. Copper binding to the octarepeats of the prion protein, Affinity, specificity, folding and cooperativity: insights from circular dichroism. J. Biol. Chem. 278:6795-802
73. 72a. Walter ED, Chattopadhyay M, Millhauser GL. 2006. The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. Biochemistry 45:13083-92
74. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM. 1999. Normal prion protein has an activity like that of Superoxide dismutase. Biochem. J. 344:1-5
75. Brown DR. 2001. Prion and prejudice: normal protein and the synapse. Trends Neurosci. 24:85-90
76. Bonomo RP, Impellizzeri G, Pappalardo G, Rizzarelli E, Tabbi G. 2000. Copper(II) binding modes in the prion octarepeat PHGGGWGQ: a spectroscopic and voltammetric study. Chem. Eur. J. 6:4195-202
77. May PM, Linder PW, Williams DR. 1977. Computer simulation of metal-ion equilibria in biofluids: models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in human blood plasma. J. Chem. Soc. Dalton Trans. 1977:588-95
78. Harford C, Sarkar B. 1997. Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides: metal binding, DNA cleavage, and other properties. Acc. Chem. Res. 30:123-30
79. Drisaldi B, CoomaraswamyJ, Mastrangelo P, Strome B, Yang J, et al. 2004. Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset proapoptotic activity of the Doppel helix B/B′ region. J. Biol. Chem. 279:55443-54
80. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, et al. 2004. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303:1514-16
81. Kim BH, Lee HG, Choi JK, Kim JI, Choi EK, et al. 2004. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res. Mol. Brain Res. 124:40-50
82. Mufti AR, Burstein E, Csomos RA, Graf PC, Wilkinson JC, et al. 2006. XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mot. Cell 21:775-85
83. Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, et al. 2000. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27:399-408
84. Goldfarb LG, Brown P, McCombie WR, Goldgaber D, Swergold GD, et al. 1991. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl. Acad. Sci. USA 88:10926-30
85. Quaglio E, Chiesa R, Harris DA. 2001. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J. Biol. Chem. 276:11432-38
86. Bocharova OV, Breydo L, Salnikov W, Baskakov IV. 2005. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 44:6776-87
87. C may inhibit prion disease propagation. Brain Res. 993:192-200
88. Wadsworth DF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. 1999. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1:55-59
89. Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp R, et al. 2003. Copper chelation delays the onset of prion disease. J. Biol. Chem. 278:46199-202
90. Cox DL, Pan J, Singh RR. 2 006. A mechanism for copper inhibition of infectious prion conversion. Biophys. J. 91:L11-13
91. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, et al. 2005. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-39
92. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. 2003. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100:330-35
93. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-89
94. Bush AI. 2003. The metallobiology of Alzheimer's disease. Trends Neurosci. 26:207-14
95. Rachidi W, Mange A, Senator A, Guiraud P, Riondel J, et al. 2003. Prion infection impairs copper binding of cultured cells. J. Biol. Chem. 278:14595-98